NPM1 and Ewing sarcoma: It suggested that NPM overexpression was a potential independent predictor of poor prognosis in most solid tumors, including Ewing’s sarcoma, hepatocellular carcinoma, gastric cancer, ovarian serous cancer, colorectal carcinomas, glioma, astrocytoma, pancreatic adenocarcinoma and bladder carcinoma.